undamentalytics Newsletter

Adapthealth Corp. insider trading

Every open-market purchase and sale by Adapthealth Corp.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
Adapthealth Corp. insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Adapthealth Corp.’s insiders pay?

From December 20, 2019 to August 10, 2026, 20 insiders reported 26 open-market purchases and 35 sales not made under a pre-set plan in Adapthealth Corp. Twelve months after each purchase was reported, the shares were −17.9% against the S&P 500 on average (median −37.6%), over 20 purchases with a full year of prices; 20% beat the index. After sales, the shares moved −60.2% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on December 23, 2019 into $4,894 by November 2, 2026, −9.9% a year. It held shares 72% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $20,453 (+11.0% a year), and held throughout $25,901 (+14.9%).

$0$20.0k$40.0k 20192020202120222023202420252026 $25.9k$20.5k$4.9k
Copying Adapthealth Corp.'s insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by Adapthealth Corp.'s insiders from December 23, 2019, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 72% of the time.
Adapthealth Corp.: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Everest Hill Group Inc. Other 0 — — 15 −80.7% (15) February 8, 2023
Wolf Dale B Director 5 +50.0% (3) 33% 1 −17.1% (1) August 10, 2026
Rietkerk Shaw COO - Centralized Services 0 — — 5 −51.4% (5) September 24, 2024
Williams David Solomon III Director 0 — — 5 −40.5% (4) December 5, 2025
Clemens Jason A Chief Financial Officer 3 −8.1% (3) 67% 1 −2.7% (1) December 12, 2024
Ebbel Matthew Director 4 −40.5% (4) 0% 0 — June 16, 2022
Skyknight Capital Fund II, L.P. Director 3 −48.9% (3) 0% 1 −50.7% (1) August 14, 2023
Griggs Stephen P Chief Executive Officer 3 −3.0% (3) 33% 0 — March 4, 2022
Assured Investment Management LLC Director 0 — — 2 −64.5% (2) December 15, 2020
Cashin Richard M Jr 10% owner 2 — — 0 — March 23, 2026
Skyknight Capital II Gp, LLC Director 2 −34.6% (2) 0% 0 — June 15, 2022
Bunting Daniel COO - Field Operations 0 — — 1 −81.3% (1) December 13, 2022
Deerfield Private Design Fund IV, L.P. 10% owner 0 — — 1 −17.3% (1) March 12, 2024
Mullen Frank Chief Accounting Officer 0 — — 1 −3.5% (1) September 27, 2021
Prast Albert A. Chief Technology Officer 0 — — 1 −50.7% (1) August 14, 2023
Quasha Alan G Director 1 −33.4% (1) 0% 0 — May 13, 2021
Rew Richard W. II CLO and General Counsel 1 — — 0 — February 27, 2026
Samet Kenneth A Director 1 — — 0 — August 10, 2026
Skyknight Aero Holdings II, LLC Director 1 −64.4% (1) 0% 0 — June 21, 2022
Weaver Susan T Director 0 — — 1 −66.1% (1) March 19, 2021

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded Adapthealth Corp.

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Adapthealth Corp. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 3 buying crowds with six months of prices, it averaged −34.5% against the index. After 2 selling crowds, −35.0%. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
August 31, 20262 buyingnot yetnot yetnot yet
March 31, 20263 buying−25.9%−70.5%not yet
November 29, 20243 selling+7.0%−11.2%−21.8%
November 30, 20223 selling−27.9%−58.8%−74.8%
December 31, 20212 buying−27.6%−5.6%−2.4%
May 28, 20213 buying−17.2%−27.5%−31.9%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

← Back to Adapthealth Corp. · Funds · Politicians